샤페론

378800KOSDAQView the 제약 sectorTheme Bio & healthcare

2,350KRWMarket close of 10/28 (Wed)

Up +0.21%+5KRWMarket close of 10/28 (Wed)

Open
2,345
High
2,380
Low
2,320
Day range
Day range low 2,320 high 2,380, open 2,345, close 2,350, previous close 2,345
Volume
2×10K shares
38.34 million KRW 0.24× the 20-session average

Market close of 10/28 (Wed)

Loading

Free · no sign-inSource from 2021-05-17

Data dateMost recent closing data10/28 (Wed)
Market close data of 2026-10-28

Points to check

  • Earningsto check-15.6B KRWOperating income over the last four quarters -15.6B KRW (loss)Operating income, 8 quarters
  • Daily movenot verifiedOnly 20 daily bars to compare, so not verified
  • Trading valuenot verifiedNot enough 20-session trading value data, so not verified

The other 2

  • Recent filingsnot verified
  • Foreign & institutionalnot verified

With 20 trading days, the 1-year position isn't calculated · First data date 9/29 (Tue)

See the full check report

Quarterly results · Q2 2026

  • Revenue41.17 million KRWRevenue bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    Turned profitable
    vs. prior quarter
    -37.0%
  • Operating income-3.1B KRWOperating income bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    Still a loss
    vs. prior quarter
    Still a loss
  • Operating margin-7,565.0%Operating margin bars for the last 6 quarters; the dark bar is this quarter
    vs. year ago
    —
    vs. prior quarter
    -1,957.2 pp

Quarterly operating income trend

As of the latest official close · 2026-10-28Valuation filing date · 2026-08-12
2023Q3 -2.6B KRW2026Q2 -3.1B KRWQ4 values are derived as the annual figure minus Q1–Q3. The value table marks them in the Type column.

Same sector · 제약

Up +0.44%

· 100 of 169 stocks up, preferred shares excluded · trading value 566.8B KRW

Same sector · top by trading value
Stock20DChangeTrading value
셀트리온Close over the last 20 sessions +6.1%Up +0.64%80.0B KRW
삼성바이오로직스Close over the last 20 sessions -0.9%Down -0.15%68.9B KRW
파마리서치Close over the last 20 sessions -27.8%Down -1.30%43.9B KRW
한미약품Close over the last 20 sessions -27.1%Up +5.42%42.3B KRW
삼익제약Close over the last 20 sessions -13.1%Up +9.54%34.5B KRW

Schedule

  • Q3 report due · 11/16 (Mon) · in 18 days
  • Next data 10/30 (Fri) after 08:50

Related news

All news
Loading

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 83% of trading value, about 93% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.